Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoantigens”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 0 results

Very early researchLooking for participantsNCT06577532
What this trial is testing

Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid Tumors

Who this might be right for
Pancreatic NeoplasmsOther Solid Tumors
Ruijin Hospital 56
Very early researchEnrolling By InvitationNCT07316361
What this trial is testing

GYNORYLAQ™-VLINIVAL™: Ψ-Guided Personalized Neoantigen Peptide Vaccine for High-Risk Endometrial Cancer

Who this might be right for
Endometrial CarcinomaEndometrial Carcinoma Stage III
Biogenea Pharmaceuticals Ltd. 40
Not applicableUnknownNCT04145232
What this trial is testing

AImmune - Artificial Intelligence Algorithm for Identification of Immunogenic Neoepitopes of Cancer to Predict and Boost Patient's Response to Immunotherapies.

Who this might be right for
Non Small Cell Lung CancerNeoepitopesNeoantigens+3 more
Ardigen 30
Not applicableLooking for participantsNCT05030805
What this trial is testing

Transcriptional Map of Ovarian Cancer at the Single Cell Level

Who this might be right for
Ovarian Cancer
University Hospital, Strasbourg, France 50
Not applicableUnknownNCT05557240
What this trial is testing

Neoantigens Phase I Trial in Newly Diagnosed Glioblastoma Patients

Who this might be right for
Glioma, MalignantAntigen-specific VaccinesIndividualized Treatment
Shanghai 10th People's Hospital 10
Testing effectiveness (Phase 2)Study completedNCT03953235
What this trial is testing

A Personalized Cancer Vaccine Targeting Shared Neoantigens

Who this might be right for
Non-Small Cell Lung CancerColorectal CancerPancreatic Cancer+2 more
Gritstone bio, Inc. 39
Early research (Phase 1)Ended earlyNCT04596033
What this trial is testing

TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy

Who this might be right for
MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of Head and Neck+6 more
Genocea Biosciences, Inc. 49
Testing effectiveness (Phase 2)Looking for participantsNCT05908643
What this trial is testing

A First-In-Human Trial of pTTL in Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Neogap Therapeutics AB 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07412197
What this trial is testing

Preventive Dendritic Cell Vaccination for Lynch Syndrome

Who this might be right for
Lynch Syndrome
Radboud University Medical Center 16
Early research (Phase 1)UnknownNCT03258359
What this trial is testing

Personalized Adoptive Cellular Therapy Targeting MDS Stem Cell Neoantigens (PACTN)

Who this might be right for
Myelodysplastic Syndromes
PersImmune, Inc 12
Not applicableNo Longer AvailableNCT04135092
What this trial is testing

Single Patient Protocol: A Phase II Study Using the Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Mutated Neoantigens in a Patient With Metastatic Cancer Plus the Administration of Pembrolizumab

National Institutes of Health Clinical Center (CC)